Sarepta Therapeutic (SRPT) PT Raised to $66 at Wedbush

September 20, 2016 7:21 AM EDT Send to a Friend
Wedbush analyst Heather Behanna reiterated an Outperform rating and boosted her price target on Sarepta Therapeutic (NASDAQ: SRPT) to $66.00 ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login